EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

Product description

After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

Read more

Products from other suppliers

EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

Contact information

Address

Telephone

Website

View all contact information